Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Medtronic Heart Valves Division
EIR
•Medtronic Heart Valves Division•October 26, 2020

Medtronic Heart Valves Division – FDA EIR, Oct 26, 2020

Record Details

An FDA inspection was conducted at Medtronic Heart Valves Division in Santa Ana, CA, from October 13 to October 26, 2020. This post-market inspection focused on the Avalus Bioprosthesis Heart Valve, covering quality system elements such as design controls, corrective and preventive actions (CAPA), production controls, complaints, and supplier controls. Two significant issues were identified, leading to FDA-483 observations. First, the company failed to adequately evaluate and investigate complaints regarding potential device specification failures, a concern also noted in a previous inspection. Specifically, 140 complaints related to valve sizing errors, where implanted valves were oversized and required replacement, were not sufficiently investigated. The firm's analysis methods for returned devices were inconsistent with production inspection methods, and reviews of Device History Records for non-returned devices lacked objective evidence or failed to address documented non-conformances and reworks. Second, Medtronic's procedures for corrective and preventive actions were inadequate. The firm did not properly analyze and assess quality data from sizing error complaints to initiate appropriate CAPA, even with a high trending of these issues. The inspection was performed under compliance programs for medical device manufacturers and premarket approval/post-market inspections. Medtronic committed to correcting Observation 1 and had already revised its trending and CAPA procedures for Observation 2, though verification was pending. The company is required to submit a formal response outlining its corrective actions.

Company
Medtronic Heart Valves Division
Inspection date
October 26, 2020
Product type
devices
Office
Los Angeles District Office
Person
  • Kirtida Patel
View Company Profile

ID · 9ed21eff-fa54-4b65-91ea-69df61d28328

Violation Codes7
21 CFR 81421 CFR 820.3021 CFR 820.100(a)21 CFR 82021 CFR 820.10021 CFR 820.198(c)21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Medtronic Heart Valves Division
  • 483 - 2020-10-26October 26, 2020

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medtronic Heart Valves Division
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.